DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is and the CUSIP is 67011XAB9. A total of 46 filers reported holding NOVOCURE LTD in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$852,812
-0.5%
1,000,0000.0%0.00%0.0%
Q2 2023$857,482
-0.2%
1,000,0000.0%0.00%0.0%
Q1 2023$859,125
-44.2%
1,000,000
-42.9%
0.00%
-66.7%
Q4 2022$1,539,713
-1.3%
1,750,0000.0%0.00%0.0%
Q3 2022$1,560,000
+3.2%
1,750,0000.0%0.00%0.0%
Q2 2022$1,512,000
-72.3%
1,750,000
-70.8%
0.00%
-62.5%
Q1 2022$5,450,000
-35.4%
6,000,000
-33.3%
0.01%
-33.3%
Q4 2021$8,437,0009,000,0000.01%
Other shareholders
NOVOCURE LTD shareholders Q1 2022
NameSharesValueWeighting ↓
BRAIDWELL LP 134,334,000$116,802,1483.85%
STEELHEAD PARTNERS LLC 46,562,000$40,485,6592.64%
DeepCurrents Investment Group LLC 40,000,000$34,578,4961.35%
WOLVERINE ASSET MANAGEMENT LLC 76,557,000$66,300,8520.78%
SHENKMAN CAPITAL MANAGEMENT INC 11,317,000$9,786,5210.74%
ABSOLUTE INVESTMENT ADVISERS, LLC 4,856,000$4,199,9000.62%
Ionic Capital Management LLC 2,000,000$1,726,3490.50%
Empyrean Capital Partners, LP 15,000,000$12,980,0000.44%
Context Capital Management, LLC 4,489$3,9030.33%
Graham Capital Management, L.P. 11,422,000$9,875,7460.30%
View complete list of NOVOCURE LTD shareholders